Alpine Global Management’s Boston Scientific BSX Stock Holding History

Alpine Global Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$903K	Buy	+21,159	New	+$1.15M	0.15%	73
2020 Q3	–	Sell	-16,912	Closed	-$594K	–	258
2020 Q2	$594K	Buy	+16,912	New	+$609K	0.1%	125
2015 Q3	–	Sell	-5,031	Closed	-$89K	–	192
2015 Q2	$89K	Buy	+5,031	New	+$89.9K	0.01%	614
2015 Q1	–	Sell	-27,918	Closed	-$370K	–	333
2014 Q4	$370K	Buy	+27,918	New	+$357K	0.07%	314

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alpine Global Management's BSX Position: Q2 2026 in Review

Alpine Global Management opened a new position in Boston Scientific (BSX) in Q2 2026: 21,159 shares worth $903K. The stake represents 0.15% of the portfolio and ranks #73 among its holdings. This is a return to the name: Alpine Global Management previously reported a position in BSX as recently as Q2 2020.

Alpine Global Management first reported a position in BSX in Q4 2014 and has held it in 4 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Alpine Global Management held 21,159 shares of Boston Scientific worth $903K as of Q2 2026.
Boston Scientific was a new Alpine Global Management position in Q2 2026.
Boston Scientific made up 0.15% of Alpine Global Management's portfolio in Q2 2026, its #73 holding.
Alpine Global Management first reported a position in Boston Scientific in Q4 2014 and has held it in 4 quarters since.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.